280 related articles for article (PubMed ID: 32440844)
1. Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome.
Cruz ILR; Freitas DFS; de Macedo PM; Gutierrez-Galhardo MC; do Valle ACF; Almeida MA; Coelho RA; Brito-Santos F; Figueiredo-Carvalho MHG; Zancopé-Oliveira RM; Almeida-Paes R
Braz J Microbiol; 2021 Mar; 52(1):5-18. PubMed ID: 32440844
[TBL] [Abstract][Full Text] [Related]
2. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622
[TBL] [Abstract][Full Text] [Related]
3. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME
Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836
[TBL] [Abstract][Full Text] [Related]
4. Sporotrichosis caused by Sporothrix brasiliensis in Argentina: Case report, molecular identification and in vitro susceptibility pattern to antifungal drugs.
Etchecopaz AN; Lanza N; Toscanini MA; Devoto TB; Pola SJ; Daneri GL; Iovannitti CA; Cuestas ML
J Mycol Med; 2020 Apr; 30(1):100908. PubMed ID: 31732417
[TBL] [Abstract][Full Text] [Related]
5. Sporotrichosis Caused by Non-Wild Type
Bernardes-Engemann AR; Tomki GF; Rabello VBS; Almeida-Silva F; Freitas DFS; Gutierrez-Galhardo MC; Almeida-Paes R; Zancopé-Oliveira RM
Front Cell Infect Microbiol; 2022; 12():893501. PubMed ID: 35694546
[TBL] [Abstract][Full Text] [Related]
6. Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis.
Freitas DF; Santos SS; Almeida-Paes R; de Oliveira MM; do Valle AC; Gutierrez-Galhardo MC; Zancopé-Oliveira RM; Nosanchuk JD
Virulence; 2015; 6(2):112-20. PubMed ID: 25668479
[TBL] [Abstract][Full Text] [Related]
7. A case of sporotrichosis caused by different Sporothrix brasiliensis strains: mycological, molecular, and virulence analyses.
Oliveira MME; Almeida-Paes R; Corrêa-Moreira D; Borba CM; Menezes RC; Freitas DFS; do Valle ACF; Schubach AO; Barros MBL; Nosanchuk JD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Mem Inst Oswaldo Cruz; 2019; 114():e190260. PubMed ID: 31644705
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil.
Brilhante RS; Rodrigues AM; Sidrim JJ; Rocha MF; Pereira SA; Gremião ID; Schubach TM; de Camargo ZP
Med Mycol; 2016 Mar; 54(3):275-9. PubMed ID: 26591009
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp. strains with distinct genetic and antifungal susceptibility backgrounds.
Ramos MLM; Almeida-Silva F; de Souza Rabello VB; Nahal J; Figueiredo-Carvalho MHG; Bernardes-Engemann AR; Poester VR; Xavier MO; Meyer W; Zancopé-Oliveira RM; Frases S; Almeida-Paes R
Braz J Microbiol; 2024 Jun; 55(2):1359-1368. PubMed ID: 38466550
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex.
Almeida-Paes R; de Oliveira LC; Oliveira MM; Gutierrez-Galhardo MC; Nosanchuk JD; Zancopé-Oliveira RM
Biomed Res Int; 2015; 2015():212308. PubMed ID: 25961005
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility and resistance of Sporothrix brasiliensis to branded and compounded itraconazole formulations.
Waller SB; Ripoll MK; Madrid IM; Acunha T; Cleff MB; Chaves FC; de Mello JRB; de Faria RO; Meireles MCA
Braz J Microbiol; 2021 Mar; 52(1):155-162. PubMed ID: 32333272
[TBL] [Abstract][Full Text] [Related]
13. Antifungal resistance on Sporothrix species: an overview.
Waller SB; Dalla Lana DF; Quatrin PM; Ferreira MRA; Fuentefria AM; Mezzari A
Braz J Microbiol; 2021 Mar; 52(1):73-80. PubMed ID: 32476087
[TBL] [Abstract][Full Text] [Related]
14. Differences in cell morphometry, cell wall topography and gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates.
Castro RA; Kubitschek-Barreira PH; Teixeira PA; Sanches GF; Teixeira MM; Quintella LP; Almeida SR; Costa RO; Camargo ZP; Felipe MS; de Souza W; Lopes-Bezerra LM
PLoS One; 2013; 8(10):e75656. PubMed ID: 24116065
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis.
Rodrigues AM; de Hoog GS; de Cássia Pires D; Brihante RS; Sidrim JJ; Gadelha MF; Colombo AL; de Camargo ZP
BMC Infect Dis; 2014 Apr; 14():219. PubMed ID: 24755107
[TBL] [Abstract][Full Text] [Related]
16. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S
J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323
[TBL] [Abstract][Full Text] [Related]
17. Feline sporotrichosis: a case series of itraconazole-resistant Sporothrix brasiliensis infection.
Nakasu CCT; Waller SB; Ripoll MK; Ferreira MRA; Conceição FR; Gomes ADR; Osório LDG; de Faria RO; Cleff MB
Braz J Microbiol; 2021 Mar; 52(1):163-171. PubMed ID: 32388779
[TBL] [Abstract][Full Text] [Related]
18. Atypical Clinical Presentation of Sporotrichosis Caused by Sporothrix globosa Resistant to Itraconazole.
Fischman Gompertz O; Rodrigues AM; Fernandes GF; Bentubo HD; de Camargo ZP; Petri V
Am J Trop Med Hyg; 2016 Jun; 94(6):1218-22. PubMed ID: 27114300
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India.
Rudramurthy SM; Shankarnarayan SA; Hemashetter BM; Verma S; Chauhan S; Nath R; Savio J; Capoor M; Kaur H; Ghosh AK; Chakrabarti A
Braz J Microbiol; 2021 Mar; 52(1):91-100. PubMed ID: 32734470
[TBL] [Abstract][Full Text] [Related]
20. Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility.
Mahmoudi S; Zaini F; Kordbacheh P; Safara M; Heidari M
Med Mycol; 2016 Aug; 54(6):593-9. PubMed ID: 26933207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]